A Study to Assess Luspatercept in Lower-risk Myelodysplastic Syndrome Participants

Study Summary

The purpose of this study is to evaluate the efficacy and safety of Luspatercept when administered at the maximum approved dose in low-risk Myelodysplastic Syndrome participants who require red blood cell transfusions.